多关节置换患者假体周围关节感染的风险
回顾性分析2003至2014年单术者手术治疗的167例假体周围关节感染(PJI)患者,其中76例有多个人工关节。10/76(13%)在第二关节发生PJI,排除同时感染后为6/72(8.3%);初始感染时菌血症者后续第二关节感染风险为20%,非菌血症者为5.2%。
要点
- 多关节置换患者第二关节PJI风险为13%(10/76),排除同时感染后为8.3%(6/72)。
- 初始PJI时菌血症者第二关节感染风险20%,非菌血症者5.2%。
- 多关节感染患者中70%(7/10)初始感染时有菌血症,单次感染患者为18.1%(12/66),P=0.0004。
核心结论
- 本研究识别的后续PJI风险为既往研究的一半。
- PJI时的菌血症是发生后续PJI的重要因素。
- 对PJI患者而言,多个人工关节可能不如既往认为的那样危险,提示抑制性抗生素可能仅在菌血症病例中需要。
研究设计与样本
- 回顾性综述了2003年至2014年由单术者手术治疗的167例PJI患者。
- 76例患者有多个人工关节。
- 识别了初始与后续感染之间的时间、菌血症及PJI危险因素。
主要发现
- 76例多关节患者中13%(10/76)在第二部位发生PJI。
- 排除同时感染后,第二部位PJI发生率为8.3%(6/72)。
- 多关节感染患者中70%(7/10)初始感染时有菌血症,单次感染患者为18.1%(12/66),P=0.0004。
- 排除4例同时感染(均有菌血症)后,菌血症者第二关节感染风险为20%,非菌血症者为5.2%。
- 单次PJI患者平均随访4.6年(范围0.03-13.6年)。
关键数值与推荐
- 多关节患者第二部位PJI风险为13%(10/76)。
- 排除同时感染后第二部位PJI风险为8.3%(6/72)。
- 多关节感染患者菌血症比例为70%(7/10),单次感染患者为18.1%(12/66),P=0.0004。
- 排除4例同时感染后,菌血症者第二关节感染风险为20%,非菌血症者为5.2%。
- 多关节患者中免疫抑制、糖尿病、肾衰竭、吸烟或使用类固醇的发生率为57%。
临床怎么用
- 作者认为多个人工关节对PJI患者可能不如既往认为的那样危险,提示抑制性抗生素可能仅在菌血症病例中需要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Risk of subsequent periprosthetic joint infection (PJI) in a second prosthetic joint following initial PJI has been shown to be 19%-20%. We sought to identify (1) the risk of developing a second PJI for our patients with multiple prosthetic joints and (2) the effect of bacteremia on development of a subsequent PJI. METHODS: We retrospectively reviewed all patients treated surgically for PJI by a single surgeon from 2003 to 2014. Time between initial and subsequent infection, bacteremia, and risk factors for PJI were identified. RESULTS: Of 167 patients treated for PJI, 76 had multiple prosthetic joints. Thirteen percent (10/76) developed a PJI in a second location. Excluding simultaneous infections, the rate was 8.3% (6/72), despite having a 57% incidence of immunosuppression, diabetes, renal failure, smoking, or steroid use. Average follow-up for patients with 1 PJI was 4.6 years (range 0.03-13.6). Seventy percent (7/10) of patients with multiple infections were bacteremic at the time of initial infection compared to 18.1% (12/66) of patients with a single infection (P = .0004). Excluding the 4 simultaneous infections (all bacteremic), the risk of developing an infection in a second joint was 20% if bacteremic and 5.2% if not bacteremic. CONCLUSION: Our study identified the risk of developing a subsequent PJI to be one half of previous studies. Bacteremia at the time of PJI is an important factor for developing subsequent PJI. Multiple prosthetic joints may be less hazardous than previously thought for patients with PJI suggesting that suppressive antibiotics may only be necessary in cases with bacteremia.
引用
- Abblitt WP, Chan EW, Shinar AA, et al. Risk of Periprosthetic Joint Infection in Patients With Multiple Arthroplasties. J Arthroplasty. 2017. PMID: 29129616. doi:10.1016/j.arth.2017.10.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。